Transposable element dysregulation in systemic lupus erythematosus and regulation by histone conformation and Hsp90

Copyright © 2018 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 197(2018) vom: 08. Dez., Seite 6-18
1. Verfasser: Kelly, Maurer (VerfasserIn)
Weitere Verfasser: Lihua, Shi, Zhe, Zhang, Li, Song, Yoselin, Paucar, Michelle, Petri, Sullivan Kathleen, E
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Adar Epigenetics Heat shock Histone deacetylase inhibitor Lupus RNaseL DNA Transposable Elements mehr... HSP90 Heat-Shock Proteins Histone Deacetylase Inhibitors Histones Immunologic Factors Interferon Inducers Interferon-alpha Interferon-beta 77238-31-4 Poly I-C O84C90HH2L
LEADER 01000naa a22002652 4500
001 NLM287871800
003 DE-627
005 20231225055019.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2018.08.011  |2 doi 
028 5 2 |a pubmed24n0959.xml 
035 |a (DE-627)NLM287871800 
035 |a (NLM)30149120 
035 |a (PII)S1521-6616(18)30293-6 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Kelly, Maurer  |e verfasserin  |4 aut 
245 1 0 |a Transposable element dysregulation in systemic lupus erythematosus and regulation by histone conformation and Hsp90 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 07.10.2019 
500 |a Date Revised 01.12.2019 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2018 Elsevier Inc. All rights reserved. 
520 |a Systemic lupus erythematosus (SLE) represents an autoimmune disease in which activation of the type I interferon pathway leads to dysregulation of tolerance and the generation of autoantibodies directed against nuclear constituents. The mechanisms driving the activation of the interferon pathway in SLE have been the subject of intense investigation but are still incompletely understood. Transposable elements represent an enormous source of RNA that could potentially stimulate the cell intrinsic RNA-recognition pathway, leading to upregulation of interferons. We used RNA-seq to define transposable element families and subfamilies in three cell types in SLE and found diverse effects on transposable element expression in the three cell types and even within a given family of transposable elements. When potential mechanisms were examined, we found that Hsp90 inhibition could drive increased expression of multiple type of transposable elements. Both direct inhibition and the delivery of a heat shock itself, which redirects heat shock regulators (including Hsp90) off of basal expression promoters and onto heat shock-responsive promoters, led to increased transposable element expression. This effect was amplified by the concurrent delivery of a histone deacetylase inhibitor. We conclude that transposable elements are dysregulated in SLE and there are tissue-specific effects and locus-specific effects. The magnitude of RNAs attributable to transposable elements makes their dysregulation of critical interest in SLE where transposable element RNA complexed with proteins has been shown to drive interferon expression 
650 4 |a Journal Article 
650 4 |a Research Support, N.I.H., Extramural 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Adar 
650 4 |a Epigenetics 
650 4 |a Heat shock 
650 4 |a Histone deacetylase inhibitor 
650 4 |a Lupus 
650 4 |a RNaseL 
650 7 |a DNA Transposable Elements  |2 NLM 
650 7 |a HSP90 Heat-Shock Proteins  |2 NLM 
650 7 |a Histone Deacetylase Inhibitors  |2 NLM 
650 7 |a Histones  |2 NLM 
650 7 |a Immunologic Factors  |2 NLM 
650 7 |a Interferon Inducers  |2 NLM 
650 7 |a Interferon-alpha  |2 NLM 
650 7 |a Interferon-beta  |2 NLM 
650 7 |a 77238-31-4  |2 NLM 
650 7 |a Poly I-C  |2 NLM 
650 7 |a O84C90HH2L  |2 NLM 
700 1 |a Lihua, Shi  |e verfasserin  |4 aut 
700 1 |a Zhe, Zhang  |e verfasserin  |4 aut 
700 1 |a Li, Song  |e verfasserin  |4 aut 
700 1 |a Yoselin, Paucar  |e verfasserin  |4 aut 
700 1 |a Michelle, Petri  |e verfasserin  |4 aut 
700 1 |a Sullivan Kathleen, E  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 197(2018) vom: 08. Dez., Seite 6-18  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:197  |g year:2018  |g day:08  |g month:12  |g pages:6-18 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2018.08.011  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 197  |j 2018  |b 08  |c 12  |h 6-18